Royal Bank of Canada
LMAT icon

Royal Bank of Canada’s LeMaitre Vascular LMAT Stock Holding History

Royal Bank of Canada’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.8M Sell
272,654
-18,448
-6% -$1.76M 0.01% 1193
2025
Q4 		$23.6M Buy
291,102
+14,274
+5% +$1.23M ﹤0.01% 1389
2025
Q3 		$24.2M Sell
276,828
-34,799
-11% -$3.11M ﹤0.01% 1489
2025
Q2 		$25.9M Buy
311,627
+197,451
+173% +$16.5M ﹤0.01% 1350
2025
Q1 		$9.58M Buy
114,176
+1,735
+2% +$161K ﹤0.01% 1778
2024
Q4 		$10.4M Sell
112,441
-10,277
-8% -$988K ﹤0.01% 1775
2024
Q3 		$11.4M Buy
122,718
+6,007
+5% +$520K ﹤0.01% 1695
2024
Q2 		$9.6M Sell
116,711
-1,861
-2% -$137K ﹤0.01% 1702
2024
Q1 		$7.87M Buy
118,572
+2,355
+2% +$145K ﹤0.01% 1857
2023
Q4 		$6.6M Buy
116,217
+6,010
+5% +$315K ﹤0.01% 2042
2023
Q3 		$6.01M Buy
110,207
+4,593
+4% +$272K ﹤0.01% 1963
2023
Q2 		$7.11M Sell
105,614
-2,287
-2% -$140K ﹤0.01% 1845
2023
Q1 		$5.55M Sell
107,901
-185
-0.2% -$8.98K ﹤0.01% 1998
2022
Q4 		$4.97M Buy
108,086
+935
+0.9% +$43.8K ﹤0.01% 2155
2022
Q3 		$5.43M Buy
107,151
+2,084
+2% +$104K ﹤0.01% 2013
2022
Q2 		$4.79M Buy
105,067
+3,011
+3% +$135K ﹤0.01% 2135
2022
Q1 		$4.74M Buy
102,056
+5,362
+6% +$240K ﹤0.01% 2301
2021
Q4 		$4.86M Buy
96,694
+7,905
+9% +$409K ﹤0.01% 2396
2021
Q3 		$4.71M Buy
88,789
+10,802
+14% +$608K ﹤0.01% 2341
2021
Q2 		$4.76M Buy
77,987
+5,711
+8% +$303K ﹤0.01% 2339
2021
Q1 		$3.52M Sell
72,276
-2,697
-4% -$126K ﹤0.01% 2521
2020
Q4 		$3.04M Buy
74,973
+893
+1% +$31.9K ﹤0.01% 2559
2020
Q3 		$2.41M Buy
74,080
+2,132
+3% +$64K ﹤0.01% 2535
2020
Q2 		$1.9M Buy
71,948
+3,061
+4% +$80K ﹤0.01% 2659
2020
Q1 		$1.72M Buy
68,887
+5,333
+8% +$165K ﹤0.01% 2603
2019
Q4 		$2.28M Buy
63,554
+15,120
+31% +$522K ﹤0.01% 2780
2019
Q3 		$1.66M Buy
48,434
+7,418
+18% +$237K ﹤0.01% 2915
2019
Q2 		$1.15M Buy
41,016
+5,111
+14% +$142K ﹤0.01% 3198
2019
Q1 		$1.11M Buy
35,905
+5,897
+20% +$157K ﹤0.01% 3121
2018
Q4 		$709K Buy
30,008
+2,223
+8% +$60.7K ﹤0.01% 3438
2018
Q3 		$1.08M Buy
27,785
+11,252
+68% +$405K ﹤0.01% 3305
2018
Q2 		$554K Buy
16,533
+3,444
+26% +$123K ﹤0.01% 3713
2018
Q1 		$475K Buy
13,089
+2,520
+24% +$87.3K ﹤0.01% 3745
2017
Q4 		$336K Buy
10,569
+2,240
+27% +$76.7K ﹤0.01% 4084
2017
Q3 		$311K Buy
8,329
+3,298
+66% +$112K ﹤0.01% 4163
2017
Q2 		$157K Buy
5,031
+4,505
+856% +$130K ﹤0.01% 4508
2017
Q1 		$13K Sell
526
-234
-31% -$5.49K ﹤0.01% 5841
2016
Q4 		$20K Buy
+760
New +$16.9K ﹤0.01% 5762
2016
Q1 		– Sell
-22
Closed – – 6529
2015
Q4 		$0 Sell
22
-519
-96% -$7.51K ﹤0.01% 6747
2015
Q3 		$7K Sell
541
-240
-31% -$3.08K ﹤0.01% 6043
2015
Q2 		$9K Buy
+781
New +$7.69K ﹤0.01% 6088

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Royal Bank of Canada's LMAT Position: Q1 2026 in Review

Royal Bank of Canada reduced its LeMaitre Vascular (LMAT) stake by 6.3% in Q1 2026, selling an estimated $1.76M and leaving 272,654 shares worth $29.8M. The position accounts for 0.01% of the portfolio, ranked #1193.

Royal Bank of Canada first reported a position in LMAT in Q2 2015 and has held it in 41 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Royal Bank of Canada held 272,654 shares of LeMaitre Vascular worth $29.8M as of Q1 2026.
  • Royal Bank of Canada sold 18,448 LeMaitre Vascular shares in Q1 2026, an estimated $1.76M.
  • LeMaitre Vascular made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1193 holding.
  • Royal Bank of Canada first reported a position in LeMaitre Vascular in Q2 2015 and has held it in 41 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.